The ESMO Deep Dive: Gynaecological Cancers – Are We Defeating Cervical Cancer? 2026, organized by the European Society for Medical Oncology (ESMO), will take place on November 18, 2026, at 6:30 PM CET (9:30 PM AMT) as a live virtual webinar.

The session will review recent progress and remaining challenges in cervical cancer management, including pembrolizumab combined with concurrent chemoradiation for locally advanced disease, the role of immune checkpoint inhibitors in recurrent or metastatic cervical cancer, and treatment options after progression on immunotherapy.

The expert discussion will examine how these developments are changing clinical practice and what questions remain as systemic treatment strategies continue to evolve. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.